Our findings pinpoint AGXT—a gene encoding alanine–glyoxylate aminotransferase—as a critical mediator of GAstV-associated metabolic dysregulation, offering novel insights into the intersection of viral infection and gout pathophysiology. This evidence concerns the gene AGXT and gout.